Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma.
Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma.
复制标题
DOI:
10.3389/fonc.2021.705440
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Nonomura N
中科院分区:
文献类型:
--
作者:
Hayashi Y;Fujita K;Netto GJ;Nonomura N
Urothelial carcinoma (UC) is a common urological malignancy with a high rate of disease recurrence. Telomerase activity, a hallmark of cancer characterized by overcoming the replicative senescence, is upregulated in over 90% of patients with UC. Somatic mutations in the promoter region of telomerase reverse transcriptase (TERT) are frequently detected in UC, and drive telomerase activity. Recent studies have demonstrated a strong association between TERT promoter mutation and tumorigenesis of UC. Also, TERT promoter mutation has great potential for diagnosis, as well as prognosis in UC treatment, and this is also applicable for the liquid biopsy techniques. In this review, we discuss the progress in these areas and highlight the challenges, clinical potential, and future direction for developing UC treatment methods.
登录
查看更多内容
影响因子:
5.6
作者:
Hayashi T;Fujita K;Hayashi Y;Hatano K;Kawashima A;McConkey DJ;Nonomura N
通讯作者:
Nonomura N
影响因子:
3.3
作者:
Cowan ML;Springer S;Nguyen D;Taheri D;Guner G;Mendoza Rodriguez MA;Wang Y;Kinde I;Del Carmen Rodriguez Pena M;VandenBussche CJ;Olson MT;Cunha I;Fujita K;Ertoy D;Kinzler K;Bivalacqua T;Papadopoulos N;Vogelstein B;Netto GJ
通讯作者:
Netto GJ
DOI:
10.1038/modpathol.2016.53
发表时间:
2016-05
期刊:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
影响因子:
--
作者:
Cowan M;Springer S;Nguyen D;Taheri D;Guner G;Rodriguez MA;Wang Y;Kinde I;VandenBussche CJ;Olson MT;Cunha I;Fujita K;Ertoy D;Bivalacqua TJ;Kinzler K;Vogelstein B;Netto GJ;Papadopoulos N
通讯作者:
Papadopoulos N
影响因子:
3.9
作者:
Fan, Xing;Wang, Yinyan;Jiang, Tao
通讯作者:
Jiang, Tao
影响因子:
11.5
作者:
Bai, Xue;Kong, Yan;Si, Lu
通讯作者:
Si, Lu